Litcius/Paper detail

Restoring glutamate receptor signaling in pancreatic alpha cells rescues glucagon responses in type 1 diabetes

Julia K. Panzer, Alejandro Tamayo, Alejandro Caicedo

2022Cell Reports27 citationsDOIOpen Access PDF

Abstract

Glucagon secretion from pancreatic alpha cells is crucial to prevent hypoglycemia. People with type 1 diabetes lose this glucoregulatory mechanism and are susceptible to dangerous hypoglycemia for reasons still unclear. Here we determine that alpha cells in living pancreas slices from donors with type 1 diabetes do not mount an adequate glucagon response and cannot activate the positive autocrine feedback mediated by AMPA/kainate glutamate receptors. This feedback is required to elicit full glucagon responses in the healthy state. Reactivating residual AMPA/kainate receptor function with positive allosteric modulators restores glucagon secretion in human slices from donors with type 1 diabetes as well as glucose counterregulation in non-obese diabetic mice. Our study thus identifies a defect in autocrine signaling that contributes to alpha cell failure. The use of positive allosteric modulators of AMPA/kainate receptors overcomes this deficiency and prevents hypoglycemia, an effect that could be used to improve the management of diabetes.

Topics & Concepts

Kainate receptorGlucagonAMPA receptorEndocrinologyAlpha cellHypoglycemiaInternal medicineType 2 diabetesAutocrine signallingGlutamate receptorReceptorInsulinBiologyDiabetes mellitusMedicineBeta cellIsletPancreatic function and diabetesDiabetes and associated disordersDiabetes Treatment and Management